AMPYRA

Acorda Therapeutics, Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 16, 2026
Approval ID: 550eb76a-e4a6-4fa1-ad65-c0fd8b0ce783
Products: 1 registered
Version: 18

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA (dalfampridine) extended-release tablets, for oral use Initial U.S. Approval: 2010

Quick Stats

Total Products1

Labelers3

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.